Diabetes and Homeostasis: How Dysglycemia Disrupts Body Balance

Diabetes as a Systemic Homeostatic Disruptor

Diabetes mellitus (Type 1 and Type 2) fundamentally disrupts glucose homeostasis, triggering a cascade of disturbances across multiple physiological systems.

1. Blood Glucose Dysregulation

  • Type 1: Absolute insulin deficiency → unchecked hepatic glucose output, no peripheral uptake → severe hyperglycemia.
  • Type 2: Insulin resistance + relative insulin deficiency → impaired glucose uptake, increased hepatic gluconeogenesis/glycogenolysis → hyperglycemia.

2. Impaired Insulin Signaling

Insulin resistance in muscle, liver, adipose tissue disrupts glucose/lipid/protein metabolism. Alters PI3K/Akt and MAPK pathways.

3. Increased Hepatic Glucose Production

Unsuppressed gluconeogenesis and glycogenolysis worsen hyperglycemia, especially overnight (dawn phenomenon).

4. Dehydration and Electrolyte Imbalance

Hyperglycemia → osmotic diuresis → polyuria → water/electrolyte loss (Na⁺, K⁺, Mg²⁺, phosphate) → hypovolemia, hypotension, arrhythmia risk.

5. Cardiovascular Complications

  • Accelerated atherosclerosis (endothelial dysfunction, oxidative stress, inflammation).
  • Hypertension (volume overload, vascular stiffness, RAAS activation).
  • Diabetic cardiomyopathy.

6. Impaired Wound Healing

Microvascular disease, neuropathy, immune dysfunction, hyperglycemia-impaired leukocyte function → chronic ulcers, infection risk.

7. Neuropathy (Peripheral & Autonomic)

Metabolic (polyol pathway, AGEs), vascular, and oxidative damage to nerves → sensory loss, pain, gastroparesis, orthostatic hypotension, bladder dysfunction, cardiac denervation.

8. Nephropathy

Hyperfiltration → glomerular hypertension → proteinuria → declining GFR → ESRD. Disrupts fluid/electrolyte/acid-base homeostasis.

9. Retinopathy

Microvascular damage → ischemia, neovascularization, edema → vision loss/blindness.

Restoring Homeostasis

Requires multifactorial management: glycemic control (HbA1c target), blood pressure control, lipid management, RAAS blockade, SGLT2 inhibitors/GLP-1 RAs (cardio-renal protection), lifestyle, screening.

Diabetes - Related Articles